INSIGHTS ON DRUG DEVELOPMENT

• From Nanoformed Powder To 3D Printable Ink

  3D printing in pharmaceutics is advancing to offer innovative drug delivery applications. Explore the possibilities of forming stable suspension in printing ink from nanoformed materials.

• Partnering On An Innovative Hydrogel-Based Treatment For Glioblastoma

  Treatments for glioblastoma multiforme (GBM) are in high demand. Learn more about the new possibilities for increased dosing and diffusion capabilities offered by nanoformed APIs.

• The Future Of Small And Large Molecule Bioanalytics — Today

  Learn how innovative, emerging technologies are revolutionizing the field of bioanalytics and drug development.

• CDMO Outsourcing Trends & Benefits In Biologics Manufacturing

  The demand for biologics is projected to rise over the next decade. Explore the benefits of partnering with a CDMO as you aim to bring your drug to market.

• Leveraging The Bolar Exemption To Accelerate Market Access

  3/17/2023

  Gain insight into the changing comparator sourcing landscape, focusing specifically on the instrumental role the Bolar exemption plays in the shift away from dependence on innovators for clinical supplies.

• Using Advanced Mass Spectrometry To Analyze APIs And Impurities

  3/17/2023

  Characterizing impurities through advanced analytics, including mass spectrometry, is a critical step in ensuring biotherapeutic product quality. Learn more about the growing role of CDMOs in developing these products.

• Allogeneic Vs. Autologous Cell Therapy: Deciding On Your Product Strategy

  3/15/2023

  As you develop your future cell therapy drug, consider the risks and benefits of using autologous or allogeneic methods to best suit your development and manufacturing needs.

• The Future Of Plasmid DNA Upstream Optimization

  3/15/2023

  An optimized upstream manufacturing process is crucial for producing the necessary amount of plasmid DNA required for the growing number of therapeutic and vaccine applications available.